NEO|Neogenomics Inc|Price:11.420|Chg%:0.15

More Details of Neogenomics Inc Company

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Neogenomics Inc Info



Ticker SymbolNEO

Company nameNeogenomics Inc

IPO dateDec 10, 2012

CEOZook (Antony P)

Number of employees2200

Security typeOrdinary Share

Fiscal year-endDec 10

Address9490 Neogenomics Way

CityFORT MYERS

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code33912

Phone12397680600

Websitehttps://neogenomics.com/

Ticker SymbolNEO

IPO dateDec 10, 2012

CEOZook (Antony P)

Company Executives of Neogenomics Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

174.72K

-11938.00%

Mr. Warren Stone

President, Chief Operating Officer

121.63K

+22127.00%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+12254.00%

Dr. Neil Gunn

Independent Director

28.10K

+12254.00%

Ms. Felicia Williams

Independent Director

7.16K

+7160.00%

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

--

Dr. Alison L. Hannah, M.D.

Independent Director

--

Mr. Michael A. Kelly

Lead Independent Director

--

Mr. David B. Perez

Independent Director

--

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

--

Name

Name/Position

Position

Shareholding

Change

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

174.72K

-11938.00%

Mr. Warren Stone

President, Chief Operating Officer

121.63K

+22127.00%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+12254.00%

Dr. Neil Gunn

Independent Director

28.10K

+12254.00%

Ms. Felicia Williams

Independent Director

7.16K

+7160.00%

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

By BusinessUSD

Name

Revenue

Proportion

Clinical Services-Client direct billing

132.29M

70.44%

Clinical Services-Commercial Insurance

32.47M

17.29%

Clinical Services-Medicare and Medicaid

22.97M

12.23%

Clinical Services-Self-Pay

69.00K

0.04%

Relevant data have not been disclosed by the company yet.

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

Clinical Services-Client direct billing

132.29M

70.44%

Clinical Services-Commercial Insurance

32.47M

17.29%

Clinical Services-Medicare and Medicaid

22.97M

12.23%

Clinical Services-Self-Pay

69.00K

0.04%

Shareholding Stats

Updated: Wed, Feb 4

Shareholders

Shareholder Types

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.66%

First Light Asset Management, LLC

7.67%

Greenhouse Funds LLLP

6.35%

Millennium Management LLC

5.01%

Other

56.71%

Shareholders

Proportion

BlackRock Institutional Trust Company, N.A.

13.59%

The Vanguard Group, Inc.

10.66%

First Light Asset Management, LLC

7.67%

Greenhouse Funds LLLP

6.35%

Millennium Management LLC

5.01%

Other

56.71%

Shareholder Types

Shareholders

Proportion

Investment Advisor

48.68%

Investment Advisor/Hedge Fund

31.57%

Hedge Fund

23.57%

Research Firm

2.97%

Individual Investor

1.31%

Pension Fund

1.26%

Bank and Trust

0.54%

Sovereign Wealth Fund

0.09%

Family Office

0.04%

Institutional Shareholding



Updated: Mon, Jan 5

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q4

572

134.68M

104.09%

-7.79M

2025Q3

568

127.88M

98.83%

-9.78M

2025Q2

571

126.82M

98.17%

-12.95M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

BlackRock Institutional Trust Company, N.A.

17.58M

13.59%

-189.58K

-1.07%

Sep 30, 2025

The Vanguard Group, Inc.

13.87M

10.72%

-227.03K

-1.61%

Sep 30, 2025

First Light Asset Management, LLC

9.93M

7.67%

+3.08M

+45.00%

Sep 30, 2025

Greenhouse Funds LLLP

8.22M

6.35%

+789.51K

+10.62%

Sep 30, 2025

Millennium Management LLC

6.48M

5.01%

+46.65K

+0.72%

Dec 02, 2025

State Street Investment Management (US)

5.02M

3.88%

-88.88K

-1.74%

Sep 30, 2025

Deerfield Management Company, L.P.

4.45M

3.44%

+2.30M

+107.05%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

3.83M

2.96%

-465.84K

-10.85%

Sep 30, 2025

Schroder Investment Management North America Inc.

3.48M

2.69%

-240.87K

-6.47%

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

State Street SPDR S&P Health Care Services ETF

2.38%

Invesco S&P SmallCap Health Care ETF

0.77%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.5%

Inspire Small/Mid Cap ESG ETF

0.32%

iShares U.S. Healthcare Providers ETF

0.2%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

0.14%

iShares S&P Small-Cap 600 Value ETF

0.12%

Nuveen ESG Small-Cap ETF

0.11%

iShares ESG Select Screened S&P Small-Cap ETF

0.1%

iShares Core S&P Small-Cap ETF

0.09%

State Street SPDR S&P Health Care Services ETF

Proportion2.38%

Invesco S&P SmallCap Health Care ETF

Proportion0.77%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proportion0.5%

Inspire Small/Mid Cap ESG ETF

Proportion0.32%

iShares U.S. Healthcare Providers ETF

Proportion0.2%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

Proportion0.14%

iShares S&P Small-Cap 600 Value ETF

Proportion0.12%

Nuveen ESG Small-Cap ETF

Proportion0.11%

iShares ESG Select Screened S&P Small-Cap ETF

Proportion0.1%

iShares Core S&P Small-Cap ETF

Proportion0.09%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data